Surrozen, Inc. (NASDAQ:SRZNW) Sees Large Decrease in Short Interest

Surrozen, Inc. (NASDAQ:SRZNW) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 11,800 shares, a decrease of 42.2% from the March 31st total of 20,400 shares. Based on an average trading volume of 2,900 shares, the days-to-cover ratio is presently 4.1 days.

Surrozen Price Performance

Shares of NASDAQ SRZNW remained flat at $0.02 during midday trading on Friday. Surrozen has a 12 month low of $0.01 and a 12 month high of $0.12. The company’s 50-day moving average is $0.04 and its 200-day moving average is $0.03.

Surrozen Company Profile

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company is developing antibody-based therapeutics with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.